Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia
Objective To investigate the relationship between the topography of amyloid‐β plaques, tau neurofibrillary tangles, and the overlap between the two, with cognitive dysfunction in individuals without dementia. Methods We evaluated 154 individuals who were assessed with amyloid‐β PET with [18F]AZD4694...
Gespeichert in:
Veröffentlicht in: | Annals of clinical and translational neurology 2021-10, Vol.8 (10), p.2083-2092 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2092 |
---|---|
container_issue | 10 |
container_start_page | 2083 |
container_title | Annals of clinical and translational neurology |
container_volume | 8 |
creator | Therriault, Joseph Pascoal, Tharick A. Sefranek, Marcus Mathotaarachchi, Sulantha Benedet, Andrea L. Chamoun, Mira Lussier, Firoza Z. Tissot, Cécile Bellaver, Bruna Lukasewicz, Pamela S. Zimmer, Eduardo R. Saha‐Chaudhuri, Paramita Gauthier, Serge Rosa‐Neto, Pedro |
description | Objective
To investigate the relationship between the topography of amyloid‐β plaques, tau neurofibrillary tangles, and the overlap between the two, with cognitive dysfunction in individuals without dementia.
Methods
We evaluated 154 individuals who were assessed with amyloid‐β PET with [18F]AZD4694, tau‐PET with [18F]MK6240, structural MRI, and neuropsychological testing. We also evaluated an independent cohort of 240 individuals who were assessed with amyloid‐β PET with [18F]Florbetapir, tau‐PET with [18F]Flortaucipir, structural MRI, and neuropsychological testing. Using the VoxelStats toolbox, we conducted voxel‐wise linear regressions between amyloid‐PET, tau‐PET, and their interaction with cognitive function, correcting for age, sex, and years of education.
Results
In both cohorts, we observed that tau‐PET standardized uptake value ratio in medial temporal lobes was associated with clinical dementia rating Sum of Boxes (CDR‐SoB) scores independently of local amyloid‐PET uptake (FWE corrected at p |
doi_str_mv | 10.1002/acn3.51457 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_acn3_51457</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_883ae9db72494384b227a029fb4a04f1</doaj_id><sourcerecordid>2583552239</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5147-b925c3152cce16ed8866cdc756fefc3b911f830077500cfd4cc4a13bf188db413</originalsourceid><addsrcrecordid>eNqNkt9qFDEUxgdRbFl74wPIgDdS2Zq_k8yNsAz-KRS9qXdCyCQnbZaZZJ3MtOydj-Az-iRmO-vaeiFCIOGcXz6-5HxF8RyjM4wQeaNNoGccMy4eFceEErmsOaKP752PipOU1gghjAmngjwtjiirsKikPC6-rvptF739-f2HhQ0EC2EsdbClPtR9-NMB58CMqYyuvNRT6UNe1t94O-kulbd-vI7TWFroM-z1s-KJy3U42e-L4sv7d5fNx-XF5w_nzepiabJxsWxrwg3FnBgDuAIrZVUZawSvHDhD2xpjJylCQnCEjLPMGKYxbR2W0rYM00VxPuvaqNdqM_heD1sVtVd3hThcKT2M3nSgpKQaatsKwmpGJWsJERqR2rVMI-Z2Wm9nrc3U9mBNfsiguweiDzvBX6ureKMkJ5JVLAu82gsM8dsEaVS9Twa6TgeIU1KEyzw3jvJkFsXLv9B1nIaQv2pHUc4JoXWmTmfKDDGlAdzBDEZqlwG1y4C6y0CGX9y3f0B_TzwDr2fgFtrokvEQDBywnBKBGEWkQrvAZFr-P934UY8-hiZOYcxX8f6q72D7D89q1Xyis_tfXVTeVQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2583552239</pqid></control><display><type>article</type><title>Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Open Access</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Therriault, Joseph ; Pascoal, Tharick A. ; Sefranek, Marcus ; Mathotaarachchi, Sulantha ; Benedet, Andrea L. ; Chamoun, Mira ; Lussier, Firoza Z. ; Tissot, Cécile ; Bellaver, Bruna ; Lukasewicz, Pamela S. ; Zimmer, Eduardo R. ; Saha‐Chaudhuri, Paramita ; Gauthier, Serge ; Rosa‐Neto, Pedro</creator><creatorcontrib>Therriault, Joseph ; Pascoal, Tharick A. ; Sefranek, Marcus ; Mathotaarachchi, Sulantha ; Benedet, Andrea L. ; Chamoun, Mira ; Lussier, Firoza Z. ; Tissot, Cécile ; Bellaver, Bruna ; Lukasewicz, Pamela S. ; Zimmer, Eduardo R. ; Saha‐Chaudhuri, Paramita ; Gauthier, Serge ; Rosa‐Neto, Pedro ; Alzheimers Dis Neuroimaging Initia ; Alzheimer's Disease Neuroimaging Initiative ; the Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><description>Objective
To investigate the relationship between the topography of amyloid‐β plaques, tau neurofibrillary tangles, and the overlap between the two, with cognitive dysfunction in individuals without dementia.
Methods
We evaluated 154 individuals who were assessed with amyloid‐β PET with [18F]AZD4694, tau‐PET with [18F]MK6240, structural MRI, and neuropsychological testing. We also evaluated an independent cohort of 240 individuals who were assessed with amyloid‐β PET with [18F]Florbetapir, tau‐PET with [18F]Flortaucipir, structural MRI, and neuropsychological testing. Using the VoxelStats toolbox, we conducted voxel‐wise linear regressions between amyloid‐PET, tau‐PET, and their interaction with cognitive function, correcting for age, sex, and years of education.
Results
In both cohorts, we observed that tau‐PET standardized uptake value ratio in medial temporal lobes was associated with clinical dementia rating Sum of Boxes (CDR‐SoB) scores independently of local amyloid‐PET uptake (FWE corrected at p < 0.001). We also observed in both cohorts that in regions of the neocortex, associations between neocortical tau‐PET and clinical function were dependent on local amyloid‐PET (FWE corrected at p < 0.001).
Interpretation
In medial temporal brain regions, characterized by the accumulation of tau pathology in the absence of amyloid‐β, tau had direct associations with cognitive dysfunction. In brain regions characterized by the accumulation of both amyloid‐β and tau pathologies such as the posterior cingulate and medial frontal cortices, tau’s relationship with cognitive dysfunction was dependent on local amyloid‐β concentrations. Our results provide evidence that amyloid‐β in Alzheimer’s disease influences cognition by potentiating the deleterious effects of tau pathology.</description><identifier>ISSN: 2328-9503</identifier><identifier>EISSN: 2328-9503</identifier><identifier>DOI: 10.1002/acn3.51457</identifier><identifier>PMID: 34617688</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Aged ; Aged, 80 and over ; Algorithms ; Alzheimer's disease ; Amnesia - diagnostic imaging ; Amnesia - metabolism ; Amyloid beta-Peptides - metabolism ; Biomarkers ; Clinical Neurology ; Cognitive ability ; Cognitive Dysfunction - diagnostic imaging ; Cognitive Dysfunction - metabolism ; Cohort Studies ; Dementia ; Female ; Humans ; Hypotheses ; Life Sciences & Biomedicine ; Magnetic Resonance Imaging ; Male ; Medical imaging ; Middle Aged ; Neocortex - diagnostic imaging ; Neocortex - metabolism ; Neurosciences ; Neurosciences & Neurology ; Neurotoxicity ; Pathology ; Positron-Emission Tomography ; Science & Technology ; tau Proteins - metabolism</subject><ispartof>Annals of clinical and translational neurology, 2021-10, Vol.8 (10), p.2083-2092</ispartof><rights>2021 The Authors. published by Wiley Periodicals LLC on behalf of American Neurological Association.</rights><rights>2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000704302600001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c5147-b925c3152cce16ed8866cdc756fefc3b911f830077500cfd4cc4a13bf188db413</citedby><cites>FETCH-LOGICAL-c5147-b925c3152cce16ed8866cdc756fefc3b911f830077500cfd4cc4a13bf188db413</cites><orcidid>0000-0002-7826-4781 ; 0000-0003-2711-3833 ; 0000-0001-9116-1376 ; 0000-0001-9057-8014</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528464/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528464/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,1419,2106,2118,11571,27933,27934,39267,45583,45584,46061,46485,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34617688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Therriault, Joseph</creatorcontrib><creatorcontrib>Pascoal, Tharick A.</creatorcontrib><creatorcontrib>Sefranek, Marcus</creatorcontrib><creatorcontrib>Mathotaarachchi, Sulantha</creatorcontrib><creatorcontrib>Benedet, Andrea L.</creatorcontrib><creatorcontrib>Chamoun, Mira</creatorcontrib><creatorcontrib>Lussier, Firoza Z.</creatorcontrib><creatorcontrib>Tissot, Cécile</creatorcontrib><creatorcontrib>Bellaver, Bruna</creatorcontrib><creatorcontrib>Lukasewicz, Pamela S.</creatorcontrib><creatorcontrib>Zimmer, Eduardo R.</creatorcontrib><creatorcontrib>Saha‐Chaudhuri, Paramita</creatorcontrib><creatorcontrib>Gauthier, Serge</creatorcontrib><creatorcontrib>Rosa‐Neto, Pedro</creatorcontrib><creatorcontrib>Alzheimers Dis Neuroimaging Initia</creatorcontrib><creatorcontrib>Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><creatorcontrib>the Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><title>Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia</title><title>Annals of clinical and translational neurology</title><addtitle>ANN CLIN TRANSL NEUR</addtitle><addtitle>Ann Clin Transl Neurol</addtitle><description>Objective
To investigate the relationship between the topography of amyloid‐β plaques, tau neurofibrillary tangles, and the overlap between the two, with cognitive dysfunction in individuals without dementia.
Methods
We evaluated 154 individuals who were assessed with amyloid‐β PET with [18F]AZD4694, tau‐PET with [18F]MK6240, structural MRI, and neuropsychological testing. We also evaluated an independent cohort of 240 individuals who were assessed with amyloid‐β PET with [18F]Florbetapir, tau‐PET with [18F]Flortaucipir, structural MRI, and neuropsychological testing. Using the VoxelStats toolbox, we conducted voxel‐wise linear regressions between amyloid‐PET, tau‐PET, and their interaction with cognitive function, correcting for age, sex, and years of education.
Results
In both cohorts, we observed that tau‐PET standardized uptake value ratio in medial temporal lobes was associated with clinical dementia rating Sum of Boxes (CDR‐SoB) scores independently of local amyloid‐PET uptake (FWE corrected at p < 0.001). We also observed in both cohorts that in regions of the neocortex, associations between neocortical tau‐PET and clinical function were dependent on local amyloid‐PET (FWE corrected at p < 0.001).
Interpretation
In medial temporal brain regions, characterized by the accumulation of tau pathology in the absence of amyloid‐β, tau had direct associations with cognitive dysfunction. In brain regions characterized by the accumulation of both amyloid‐β and tau pathologies such as the posterior cingulate and medial frontal cortices, tau’s relationship with cognitive dysfunction was dependent on local amyloid‐β concentrations. Our results provide evidence that amyloid‐β in Alzheimer’s disease influences cognition by potentiating the deleterious effects of tau pathology.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Algorithms</subject><subject>Alzheimer's disease</subject><subject>Amnesia - diagnostic imaging</subject><subject>Amnesia - metabolism</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Biomarkers</subject><subject>Clinical Neurology</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - diagnostic imaging</subject><subject>Cognitive Dysfunction - metabolism</subject><subject>Cohort Studies</subject><subject>Dementia</subject><subject>Female</subject><subject>Humans</subject><subject>Hypotheses</subject><subject>Life Sciences & Biomedicine</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Middle Aged</subject><subject>Neocortex - diagnostic imaging</subject><subject>Neocortex - metabolism</subject><subject>Neurosciences</subject><subject>Neurosciences & Neurology</subject><subject>Neurotoxicity</subject><subject>Pathology</subject><subject>Positron-Emission Tomography</subject><subject>Science & Technology</subject><subject>tau Proteins - metabolism</subject><issn>2328-9503</issn><issn>2328-9503</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkt9qFDEUxgdRbFl74wPIgDdS2Zq_k8yNsAz-KRS9qXdCyCQnbZaZZJ3MtOydj-Az-iRmO-vaeiFCIOGcXz6-5HxF8RyjM4wQeaNNoGccMy4eFceEErmsOaKP752PipOU1gghjAmngjwtjiirsKikPC6-rvptF739-f2HhQ0EC2EsdbClPtR9-NMB58CMqYyuvNRT6UNe1t94O-kulbd-vI7TWFroM-z1s-KJy3U42e-L4sv7d5fNx-XF5w_nzepiabJxsWxrwg3FnBgDuAIrZVUZawSvHDhD2xpjJylCQnCEjLPMGKYxbR2W0rYM00VxPuvaqNdqM_heD1sVtVd3hThcKT2M3nSgpKQaatsKwmpGJWsJERqR2rVMI-Z2Wm9nrc3U9mBNfsiguweiDzvBX6ureKMkJ5JVLAu82gsM8dsEaVS9Twa6TgeIU1KEyzw3jvJkFsXLv9B1nIaQv2pHUc4JoXWmTmfKDDGlAdzBDEZqlwG1y4C6y0CGX9y3f0B_TzwDr2fgFtrokvEQDBywnBKBGEWkQrvAZFr-P934UY8-hiZOYcxX8f6q72D7D89q1Xyis_tfXVTeVQ</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Therriault, Joseph</creator><creator>Pascoal, Tharick A.</creator><creator>Sefranek, Marcus</creator><creator>Mathotaarachchi, Sulantha</creator><creator>Benedet, Andrea L.</creator><creator>Chamoun, Mira</creator><creator>Lussier, Firoza Z.</creator><creator>Tissot, Cécile</creator><creator>Bellaver, Bruna</creator><creator>Lukasewicz, Pamela S.</creator><creator>Zimmer, Eduardo R.</creator><creator>Saha‐Chaudhuri, Paramita</creator><creator>Gauthier, Serge</creator><creator>Rosa‐Neto, Pedro</creator><general>Wiley</general><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7826-4781</orcidid><orcidid>https://orcid.org/0000-0003-2711-3833</orcidid><orcidid>https://orcid.org/0000-0001-9116-1376</orcidid><orcidid>https://orcid.org/0000-0001-9057-8014</orcidid></search><sort><creationdate>202110</creationdate><title>Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia</title><author>Therriault, Joseph ; Pascoal, Tharick A. ; Sefranek, Marcus ; Mathotaarachchi, Sulantha ; Benedet, Andrea L. ; Chamoun, Mira ; Lussier, Firoza Z. ; Tissot, Cécile ; Bellaver, Bruna ; Lukasewicz, Pamela S. ; Zimmer, Eduardo R. ; Saha‐Chaudhuri, Paramita ; Gauthier, Serge ; Rosa‐Neto, Pedro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5147-b925c3152cce16ed8866cdc756fefc3b911f830077500cfd4cc4a13bf188db413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Algorithms</topic><topic>Alzheimer's disease</topic><topic>Amnesia - diagnostic imaging</topic><topic>Amnesia - metabolism</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Biomarkers</topic><topic>Clinical Neurology</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - diagnostic imaging</topic><topic>Cognitive Dysfunction - metabolism</topic><topic>Cohort Studies</topic><topic>Dementia</topic><topic>Female</topic><topic>Humans</topic><topic>Hypotheses</topic><topic>Life Sciences & Biomedicine</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Middle Aged</topic><topic>Neocortex - diagnostic imaging</topic><topic>Neocortex - metabolism</topic><topic>Neurosciences</topic><topic>Neurosciences & Neurology</topic><topic>Neurotoxicity</topic><topic>Pathology</topic><topic>Positron-Emission Tomography</topic><topic>Science & Technology</topic><topic>tau Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Therriault, Joseph</creatorcontrib><creatorcontrib>Pascoal, Tharick A.</creatorcontrib><creatorcontrib>Sefranek, Marcus</creatorcontrib><creatorcontrib>Mathotaarachchi, Sulantha</creatorcontrib><creatorcontrib>Benedet, Andrea L.</creatorcontrib><creatorcontrib>Chamoun, Mira</creatorcontrib><creatorcontrib>Lussier, Firoza Z.</creatorcontrib><creatorcontrib>Tissot, Cécile</creatorcontrib><creatorcontrib>Bellaver, Bruna</creatorcontrib><creatorcontrib>Lukasewicz, Pamela S.</creatorcontrib><creatorcontrib>Zimmer, Eduardo R.</creatorcontrib><creatorcontrib>Saha‐Chaudhuri, Paramita</creatorcontrib><creatorcontrib>Gauthier, Serge</creatorcontrib><creatorcontrib>Rosa‐Neto, Pedro</creatorcontrib><creatorcontrib>Alzheimers Dis Neuroimaging Initia</creatorcontrib><creatorcontrib>Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><creatorcontrib>the Alzheimer's Disease Neuroimaging Initiative</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of clinical and translational neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Therriault, Joseph</au><au>Pascoal, Tharick A.</au><au>Sefranek, Marcus</au><au>Mathotaarachchi, Sulantha</au><au>Benedet, Andrea L.</au><au>Chamoun, Mira</au><au>Lussier, Firoza Z.</au><au>Tissot, Cécile</au><au>Bellaver, Bruna</au><au>Lukasewicz, Pamela S.</au><au>Zimmer, Eduardo R.</au><au>Saha‐Chaudhuri, Paramita</au><au>Gauthier, Serge</au><au>Rosa‐Neto, Pedro</au><aucorp>Alzheimers Dis Neuroimaging Initia</aucorp><aucorp>Alzheimer's Disease Neuroimaging Initiative</aucorp><aucorp>the Alzheimer's Disease Neuroimaging Initiative</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia</atitle><jtitle>Annals of clinical and translational neurology</jtitle><stitle>ANN CLIN TRANSL NEUR</stitle><addtitle>Ann Clin Transl Neurol</addtitle><date>2021-10</date><risdate>2021</risdate><volume>8</volume><issue>10</issue><spage>2083</spage><epage>2092</epage><pages>2083-2092</pages><issn>2328-9503</issn><eissn>2328-9503</eissn><abstract>Objective
To investigate the relationship between the topography of amyloid‐β plaques, tau neurofibrillary tangles, and the overlap between the two, with cognitive dysfunction in individuals without dementia.
Methods
We evaluated 154 individuals who were assessed with amyloid‐β PET with [18F]AZD4694, tau‐PET with [18F]MK6240, structural MRI, and neuropsychological testing. We also evaluated an independent cohort of 240 individuals who were assessed with amyloid‐β PET with [18F]Florbetapir, tau‐PET with [18F]Flortaucipir, structural MRI, and neuropsychological testing. Using the VoxelStats toolbox, we conducted voxel‐wise linear regressions between amyloid‐PET, tau‐PET, and their interaction with cognitive function, correcting for age, sex, and years of education.
Results
In both cohorts, we observed that tau‐PET standardized uptake value ratio in medial temporal lobes was associated with clinical dementia rating Sum of Boxes (CDR‐SoB) scores independently of local amyloid‐PET uptake (FWE corrected at p < 0.001). We also observed in both cohorts that in regions of the neocortex, associations between neocortical tau‐PET and clinical function were dependent on local amyloid‐PET (FWE corrected at p < 0.001).
Interpretation
In medial temporal brain regions, characterized by the accumulation of tau pathology in the absence of amyloid‐β, tau had direct associations with cognitive dysfunction. In brain regions characterized by the accumulation of both amyloid‐β and tau pathologies such as the posterior cingulate and medial frontal cortices, tau’s relationship with cognitive dysfunction was dependent on local amyloid‐β concentrations. Our results provide evidence that amyloid‐β in Alzheimer’s disease influences cognition by potentiating the deleterious effects of tau pathology.</abstract><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>34617688</pmid><doi>10.1002/acn3.51457</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-7826-4781</orcidid><orcidid>https://orcid.org/0000-0003-2711-3833</orcidid><orcidid>https://orcid.org/0000-0001-9116-1376</orcidid><orcidid>https://orcid.org/0000-0001-9057-8014</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2328-9503 |
ispartof | Annals of clinical and translational neurology, 2021-10, Vol.8 (10), p.2083-2092 |
issn | 2328-9503 2328-9503 |
language | eng |
recordid | cdi_crossref_primary_10_1002_acn3_51457 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE; DOAJ Directory of Open Access Journals; Wiley Online Library Open Access; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Aged Aged, 80 and over Algorithms Alzheimer's disease Amnesia - diagnostic imaging Amnesia - metabolism Amyloid beta-Peptides - metabolism Biomarkers Clinical Neurology Cognitive ability Cognitive Dysfunction - diagnostic imaging Cognitive Dysfunction - metabolism Cohort Studies Dementia Female Humans Hypotheses Life Sciences & Biomedicine Magnetic Resonance Imaging Male Medical imaging Middle Aged Neocortex - diagnostic imaging Neocortex - metabolism Neurosciences Neurosciences & Neurology Neurotoxicity Pathology Positron-Emission Tomography Science & Technology tau Proteins - metabolism |
title | Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T08%3A18%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amyloid%E2%80%90dependent%20and%20amyloid%E2%80%90independent%20effects%20of%20Tau%20in%20individuals%20without%20dementia&rft.jtitle=Annals%20of%20clinical%20and%20translational%20neurology&rft.au=Therriault,%20Joseph&rft.aucorp=Alzheimers%20Dis%20Neuroimaging%20Initia&rft.date=2021-10&rft.volume=8&rft.issue=10&rft.spage=2083&rft.epage=2092&rft.pages=2083-2092&rft.issn=2328-9503&rft.eissn=2328-9503&rft_id=info:doi/10.1002/acn3.51457&rft_dat=%3Cproquest_cross%3E2583552239%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2583552239&rft_id=info:pmid/34617688&rft_doaj_id=oai_doaj_org_article_883ae9db72494384b227a029fb4a04f1&rfr_iscdi=true |